Shandong Xinhua Pharmaceutical Co Ltd (000756) — Capital Reinvestment Ratio
Shandong Xinhua Pharmaceutical Co Ltd (000756) has a Capital Reinvestment Ratio of 1.44x as of September 2023, meaning it reinvests 1% of its operating cash flow (CN¥56.11 Million) in capital expenditures (CN¥80.69 Million). See 000756 equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shandong Xinhua Pharmaceutical Co Ltd Capital Reinvestment Ratio (2015–2024)
This chart tracks Shandong Xinhua Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 10 annual periods. Check 000756 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Shandong Xinhua Pharmaceutical Co Ltd (2015–2024)
Year-by-year Capital Reinvestment Ratio for Shandong Xinhua Pharmaceutical Co Ltd from 2015 to 2024. For live market cap and broader valuation context, see Shandong Xinhua Pharmaceutical Co Ltd (000756) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.58x | CN¥367.61 Million | CN¥212.42 Million | ▼ -52.9% |
| 2023 | 1.23x | CN¥265.28 Million | CN¥325.13 Million | ▲ +279.7% |
| 2022 | 0.32x | CN¥758.24 Million | CN¥244.76 Million | ▼ -66.4% |
| 2021 | 0.96x | CN¥259.12 Million | CN¥249.23 Million | ▲ +44.2% |
| 2020 | 0.67x | CN¥420.19 Million | CN¥280.19 Million | ▼ -36.6% |
| 2019 | 1.05x | CN¥348.27 Million | CN¥366.51 Million | ▼ -12.2% |
| 2018 | 1.20x | CN¥323.91 Million | CN¥388.44 Million | ▲ +79.1% |
| 2017 | 0.67x | CN¥389.97 Million | CN¥261.11 Million | ▲ +29.6% |
| 2016 | 0.52x | CN¥439.35 Million | CN¥227.07 Million | ▲ +6.6% |
| 2015 | 0.48x | CN¥348.64 Million | CN¥169.09 Million | — |